TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Core Temperature Below 36.0 Degrees C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suppression of cancer-cell replication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Monitoring normal metabolic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measuring cancer-marker levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Blood flow volume measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Gene expression related to antibody mediated rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in W_ova1 vaccine antigen-specific T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma pharmacokinetics of migalastat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of migalastat
Endpoint domain: Adverse events/effects
Primary endpoint: Acquisition of Vancomycin Resistant Enterococcus
Endpoint domain: Adverse events/effects
Primary endpoint: Acquisition of a composite rate of healthcare-associated bacteria
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of ankle tendi-ligamentous injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Healing trajectory of venous stasis ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of fertilized oocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Plasma Sex Hormone Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Diagnosis of acute pulmonary exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Relative bioavailability of PfOS formulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of eltrombopag PfOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival (months)
Endpoint domain: Mortality/survival
Primary endpoint: Disease-specific survival (months)
Endpoint domain: Mortality/survival
Primary endpoint: hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ephedrine use
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative PTH values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: End-stage Renal Disease
Endpoint domain: Mortality/survival
Primary endpoint: Time to first coronary heart disease diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to first cerebrovascular disease diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: % Change in VO2max
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Hospitalizations and ER Visits Due to Dehydration
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in microcirculation function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to First Opioid Use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Inpatient Opioid Dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score of All Surgical Sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical record verified flexible sigmoidoscopy or colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Dose Limiting and Intolerable Treatment-Related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events (AEs), Serious Adverse Events (SAEs) and Treatment-Related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Adverse Events (AEs) by Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Angioedema Quality of Life (AE-QoL) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Clinical improvement of the lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical negativization of the virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cervical spinal surgery status after discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in consumption of fruits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in consumption of vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in self reported usage of the Hartford Mobile Market for buying fresh produce
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change of Self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change of self-management behaviour
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Detection of tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of subjects who remain alive and progression-free at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Postoperative ammonia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Coping with Toddler's Negative Emotions Scale (CTNES)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Classroom Assessment Scoring System (CLASS)
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Evaluation of fMRI techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with bacteremia
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Reduction in Target Pathology Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adverse events reported during surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of crohn's disease identified at macroscopic intraoperative assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length of areas affected by crohn's disease identified at macroscopic intraoperative assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in 2-minute walk test (2MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumor tissue saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Concordance of patient preference with delivered treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of hyponatremia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Electrolyte and metabolic outcomes
Primary endpoint: Blastulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High quality blast rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of skin microcirculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants With Detected Relative Afferent Pupillary Defect (RAPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety-Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity and specificity of the V-VST relative to VFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engraftment of ANC and Platelets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants With Disease Progression or Death at 12 Months After Baseline
Endpoint domain: Mortality/survival
Primary endpoint: Probability of Being Progression Free 12 Months After Baseline
Endpoint domain: Mortality/survival
Primary endpoint: Intraocular Pressure (IOP) at 8AM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Onset of Calf Pain (Claudication Onset Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in muscle quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in distention/bloating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: antibody response to N. meningitidis serogroup C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of PSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Podocyte loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: changes in Left Ventricular Hypertrophy (LVH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of intracardiac thrombus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in systemic microvascular endothelial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self reported quality of Life (CASP-19)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Diabetes Treatment Satisfaction (DTSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in body weight from baseline to month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in body weight from baseline to month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in body weight from baseline to month 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in body weight from baseline to month 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptomatic Intracerebral Hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Radiographic Intracerebral Hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 5-years disease-free survival (DFS)
Endpoint domain: Mortality/survival
Primary endpoint: Knee Flexion of 90 degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee Extension of -25 degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee Flexion of 120 degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee Extension of 0 degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Area under the concentration-time curve in 1 dosing interval (AUC(TAU))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in blood and hair elemental concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient satisfaction on a 4-point verbal rating scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Menopause Quality Of Life Questionnaire (MENQOL) Physical Domain Subscale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Measles specific mortality
Endpoint domain: Mortality/survival
Primary endpoint: All cause sex-specific mortality until 3 years of age
Endpoint domain: Mortality/survival
Primary endpoint: Balance dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of severe side effects
Endpoint domain: Adverse events/effects
Primary endpoint: event free survival (EFS) after 3 years
Endpoint domain: Mortality/survival
Primary endpoint: operative or postoperative bleeding complication
Endpoint domain: Adverse events/effects
Primary endpoint: Change of respiratory Synchronicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: length of invasive mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Specific IgE to wheat and omega-5 gliadin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of decrease in airway resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: High Circulating Tumor Cell Count Number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Medication Adherence: Pill Count
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline FENO (fractional exhaled nitric oxide) at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Limb fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to Overt Hepatic Encephalopathy Resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in child adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of symptomatic patients with immune response (IgM/IgG/IgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of asymptomatic patients with immune response (IgM/IgG/IgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Achieving ≥75% Improvement in PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hepatic adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Contamination rates of isolation gown and gloves
Endpoint domain: Adverse events/effects
Primary endpoint: Result of an early postpartum 75-gram oral glucose tolerance test (GTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose uptake rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in overall satisfaction relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in KSS (Knee Society Score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: genital findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: epithelial disruption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: vaginal flora changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: genital shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fruit and Vegetable Consumption, servings per week
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: maximum anterior hyoid excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum superior hyoid excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum anterior laryngeal excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum superior laryngeal excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum upper esophageal sphincter (UES) anterior-posterior opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: pyriform sinus residue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pancreatic leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: AUC of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Worst Pelvic Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Identified With Fracture Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants with significant acid base disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients completing treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of participants with treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor-to-non-tumor activity concentration ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Value of posterior cervical angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events during the long term treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Time to neurologic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of Participation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: duration of nosebleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibody concentrations against pneumococcal serotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Child Behaviour Check List (CBCL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in constant work rate exercise time (cwret)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of conditioning regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Western Aphasia Battery-Revised scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Attitudes toward seeking treatment for social anxiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intentions to seek treatment for social anxiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived behavioral control/confidence regarding seeking treatment for social anxiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean cardiac axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction of exposure to second hand smoke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of total radioactivity in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Concentration of total radioactivity in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of [14C] AZD1152 dose recovered in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Morphological characterization of the extracellular vesicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size distribution profiles characterization of the extracellular vesicles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characterization of extracellular vesicles populations by specific markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cohens kappa
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: VAS-score for pain at movement and at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCA-bolus-sum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine-IM rescue dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of brain relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Avoidance of Under-anticoagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Avoidance of Over-anticoagulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Event Rate of Stroke/Systemic Embolism
Endpoint domain: Mortality/survival
Primary endpoint: Diminution in late asthmatic response to bronchial allergen challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Swanson, Kotkin, Agler, M-Flynn, and Pelham (SKAMP) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in plasma C-peptide / plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response rate (RR) defined as CR + PR rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes